Radical Trifluoromethoxylation of Arenes Triggered by a Visible‐Light‐Mediated N−O Bond Redox Fragmentation
作者:Benson J. Jelier、Pascal F. Tripet、Ewa Pietrasiak、Ivan Franzoni、Gunnar Jeschke、Antonio Togni
DOI:10.1002/anie.201806296
日期:2018.10.15
method enables non‐directed functionalization of C−H bonds on a range of substrates, providing access to aryl trifluoromethyl ethers. This light‐driven process is distinctly different from conventional procedures and occurs through an OCF3 radical mechanism mediated by a photoredox catalyst, which triggers an N−O bond fragmentation. The pyridinium‐based trifluoromethoxylation reagent is bench‐stable and
[EN] DIFLUOROMETHOXYLATION AND TRIFLUOROMETHOXYLATION COMPOSITIONS AND METHODS FOR SYNTHESIZING SAME<br/>[FR] COMPOSITIONS DE DIFLUOROMÉTHOXYLATION ET DE TRIFLUOROMÉTHOXYLATION ET LEURS PROCÉDÉS DE SYNTHÈSE
申请人:UNIV NEW YORK STATE RES FOUND
公开号:WO2019168874A1
公开(公告)日:2019-09-06
The present invention provides a compound having the structure (I), a processing of making the compound; and a process of using the compound as a reagent for the difluoromethoxylation and trifluoromethoxylation of arenes or heteroarenes.
[EN] INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)<br/>[FR] COMPOSÉS INDOLIQUES OU ANALOGUES DE CEUX-CI UTILES DANS LE TRAITEMENT DE LA DÉGÉNÉRESCENCE MACULAIRE LIÉE À L'ÂGE (DMLA)
申请人:NOVARTIS AG
公开号:WO2012093101A1
公开(公告)日:2012-07-12
The present invention provides a compound of formula (I): a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
OXADIAZOLES AND THIADIAZOLES AS TGF-BETA INHIBITORS
申请人:Southern Research Institute
公开号:US20190125730A1
公开(公告)日:2019-05-02
The present disclosure is concerned with oxadiazole and thiadiazole analogs that are capable of inhibiting TGF-β and methods of treating cancers such as, for example, multiple myeloma and a hematologic malignancy, and methods of treating fibrotic conditions using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
[EN] COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS EN TANT QU'INHIBITEURS DE LA TYROSINE KINASE DE LA RATE
申请人:NANJING RUIJIE PHARMA CO LTD
公开号:WO2021244430A1
公开(公告)日:2021-12-09
Provided are compounds of Formula (I) which can be used as Syk inhibitors and potently as therapeutic agents against diseases mediated by Syk.